By Dr Briony Kate Larance

Conference Presentations

Larance B; Nielsen S; Hordern A; Lintzeris N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Brown A; Johnson J; Degenhardt L, 2014, 'PHARMACEUTICAL OPIOID USE AND PAIN AMONG PEOPLE WHO INJECT DRUGS: BASELINE FINDINGS FROM A PROSPECTIVE COHORT STUDY'

Nielsen S; Larance B; Lintzeris N; Holliday S; Vanderhaven M; Hordern A; Dunlop A; Haber P; Murnion B; Silsbury C; Johnson J; Demirkol A; Sadler C; Phung N; Burns L; Mattick R; Campbell G; Farrell M; Cohen M; Bruno R; Hardy M; Brown A; Houseman J; Degenhardt L, 2014, 'SEEKING TREATMENT FOR PHARMACEUTICAL OPIOID DEPENDENCE: BASELINE CHARACTERISTICS FROM AN IN-TREATMENT COHORT'

Nielsen S; Larance B; Black E; Lintzeris N; Degenhardt L; Ali R; Cohen M; Dunlop A; Bruno R; Rivas G; Brown A; Holland R, 2012, 'PAIN PREVALENCE, SEVERITY AND INTERFERENCE IN AN AUSTRALIAN OPIOID AGONIST TREATMENT SAMPLE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Black E; Larance B; Mattick R; Lintzeris N; Degenhardt L; Bruno R; Nielsen S; Murnion B; Cohen M; Ali R; Dunlop A; Holland R, 2011, 'MINIMISING THE UNINTENDED CONSEQUENCES OF OPIOID TREATMENT: DEVELOPMENT OF A DRUG BEHAVIOUR SCALE FOR USE IN AUSTRALIA', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study', in Drug and Alcohol Dependence, Vol. 206, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L, 2016, 'DEFINING PROBLEMATIC PHARMACEUTICAL OPIOID USE AMONG PEOPLE PRESCRIBED OPIOIDS FOR CHRONIC NON-CANCER PAIN: DO DIFFERENT MEASURES IDENTIFY THE SAME PATIENTS?', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500082&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nielsen S; Peacock A; Lintzeris N; Bruno R; Larance B; Degenhardt L, 2016, 'OVERDOSE KNOWLEDGE AND PERCEPTIONS OF TAKE-HOME NALOXONE FOR PATIENTS WITH CHRONIC NON-CANCER PAIN', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 56 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500153&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Moore T; O'Donnell C; Degenhardt L; Campbell G; Nielsen S; Larance B, 2016, 'PHYSICAL HEALTH AND UTILISATION OF ALCOHOL AND OTHER DRUG TREATMENT AMONG A SAMPLE OF CHRONIC NON-CANCER PAIN PATIENTS DEPENDENT ON THEIR OPIOID MEDICATION', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 55 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Ali R; Farrell M; Peacock A; Bruno R; Lintzeris N; Dobbins T; Degenhardt L, 2016, 'THE IMPACT OF REFORMULATED OXYCONTIN (R) IN AUSTRALIA: KEY FINDINGS FROM THE NATIONAL OPIOID MEDICATIONS ABUSE DETERRENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 47 - 47, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gisev N; Pearson S-A; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Cama E; Bruno R; Farrell M; Ali R; Lintzeris N; Peacock A; Kihas I; Hordern T; White N; Degenhardt L, 2014, 'PATTERNS OF OPIOID CONSUMPTION IN A COHORT OF PEOPLE WHO TAMPER WITH PHARMACEUTICAL OPIOIDS: BASELINE FINDINGS FROM THE NATIONAL OPIOID MEDICATION ABUSE DETERRENCE (NOMAD) STUDY', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Larance BK; Degenhardt LJ; Mattick RP; O Brien SM; Lintzeris N; Bell JR; Winstock A; Ali RL, 2009, The diversion and injection of the pharmaceutical opioids used in opiod substitution treatment (OST): Findings from the Australian post-marketing surveillance studies of buprenorphine-naloxone 2006-2008, National Drug and Alcohol Research Centre, Sydney, NSW, 302, http://ndarc.med.unsw.edu.au/resource/diversion-and-injection-pharmaceutical-opioids-used-opioid-substitution-treatment-findings

Dennington V; Finney Lamb CE; Dillon PG; Larance BK; Vial R; Copeland J; Newcombe D; Ali RL, 2008, Qualitative Field Study for Users of Performance and Image Enhancing Drug, Drug and Alcohol Services South Australia, Adelaide

Degenhardt LJ; Larance BK; Mathers BM; Azim T; Kamarulzaman A; Mattick RP, 2007, Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV., Sydney: National Drug and Alcohol Research Centre, University of NSW., Sydney, Reference Group to the United Nations on HIV and injecting drug use Thematic Paper Series No. 2/2007., 2/2007, http://ndarc.med.unsw.edu.au/resource/benefits-and-risks-pharmaceutical-opioids-essential-treatment-and-diverted-medication

Larance BK; Degenhardt LJ, 2007, Performance and image enhancing drugs (PIEDs): Current trends and future monitoring., Sydney: National Drug and Alcohol Research Centre, University of New South Wales, Sydney, IDRS Drug Trends Bulletin, June 2007, June 2007

Gibson AE; Larance BK; Roxburgh AD; Degenhardt LJ; Black E, 2006, The extent of diversion of fentanyl for non-medical purposes in Australia: What do we know?, National Drug and Alcohol Research Centre, University of New South Wales,, Sydney, 265

Roxburgh AD; Degenhardt LJ; Larance BK; Copeland J, 2005, Mental Health, Drug use and risk among female street-based sex workers in Greater Sydney, National Drug & Alcohol Research Centre, Randwick, NSW, Mental Health, Drug use and risk among female street-based sex workers in Greater Sydney

Larance BK; Degenhardt LJ; Dillon PG; Copeland J, 2005, Rapid assessment of performance and image enhancing drugs (PIEDs) in New South Wales: Feasibility study 2005, National Drug & Alcohol Research Centre, Randwick, NSW, NDARC Technical Reports, 239

Larance BK; Degenhardt LJ; Dillon PG; Copeland J, 2005, Use of performance and image enhancing drugs among men: A review, National Drug & Alcohol Research Centre, Randwick, NSW, Use of performance and image enhancing drugs among men: A review

Preprints

Kelly PJ; Beck AK; Deane FP; Larance B; Baker AL; Hides L; Manning V; Shakeshaft A; Neale J; Kelly JF; Oldmeadow C; Searles A; Palazzi K; Lawson K; Treloar C; Gray RM; Argent A; McGlaughlin R, 2020, Feasibility of a Mobile Health App for Routine Outcome Monitoring and Feedback in SMART Recovery Mutual Support Groups: Stage 1 Mixed Methods Pilot Study (Preprint), , http://dx.doi.org/10.2196/preprints.25217

Back to profile page